Zealand Pharma As Stock Market Capitalization
ZEAL Stock | DKK 626.00 15.00 2.45% |
Zealand Pharma AS fundamentals help investors to digest information that contributes to Zealand Pharma's financial success or failures. It also enables traders to predict the movement of Zealand Stock. The fundamental analysis module provides a way to measure Zealand Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zealand Pharma stock.
Zealand |
Zealand Pharma AS Company Market Capitalization Analysis
Zealand Pharma's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Zealand Pharma Market Capitalization | 11.16 B |
Most of Zealand Pharma's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zealand Pharma AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Competition |
Based on the recorded statements, the market capitalization of Zealand Pharma AS is about 11.16 B. This is 13.76% lower than that of the Healthcare sector and 135.43% higher than that of the Biotechnology industry. The market capitalization for all Denmark stocks is 41.35% higher than that of the company.
Zealand Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zealand Pharma's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zealand Pharma could also be used in its relative valuation, which is a method of valuing Zealand Pharma by comparing valuation metrics of similar companies.Zealand Pharma is currently under evaluation in market capitalization category among related companies.
Zealand Fundamentals
Return On Equity | -1.44 | |||
Return On Asset | -0.48 | |||
Operating Margin | (3.82) % | |||
Current Valuation | 10.33 B | |||
Shares Outstanding | 51.28 M | |||
Shares Owned By Insiders | 0.07 % | |||
Shares Owned By Institutions | 56.21 % | |||
Price To Earning | 12.66 X | |||
Price To Book | 27.77 X | |||
Price To Sales | 36.73 X | |||
Revenue | 292.57 M | |||
Gross Profit | 173.75 M | |||
EBITDA | (982.6 M) | |||
Net Income | (1.02 B) | |||
Cash And Equivalents | 1.28 B | |||
Cash Per Share | 29.66 X | |||
Total Debt | 647.91 M | |||
Debt To Equity | 0.10 % | |||
Current Ratio | 4.19 X | |||
Book Value Per Share | 7.91 X | |||
Cash Flow From Operations | (1.21 B) | |||
Earnings Per Share | (23.13) X | |||
Price To Earnings To Growth | 0.31 X | |||
Target Price | 243.75 | |||
Number Of Employees | 203 | |||
Beta | 0.95 | |||
Market Capitalization | 11.16 B | |||
Total Asset | 2.07 B | |||
Retained Earnings | 154 M | |||
Working Capital | 463 M | |||
Current Asset | 517 M | |||
Current Liabilities | 54 M | |||
Z Score | 10.2 | |||
Net Asset | 2.07 B |
About Zealand Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zealand Pharma AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zealand Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zealand Pharma AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zealand Pharma AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Zealand Stock analysis
When running Zealand Pharma's price analysis, check to measure Zealand Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zealand Pharma is operating at the current time. Most of Zealand Pharma's value examination focuses on studying past and present price action to predict the probability of Zealand Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zealand Pharma's price. Additionally, you may evaluate how the addition of Zealand Pharma to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |